Grand Rounds Recap 9.21.2022


Clinical Knowledge: Acute Urinary Retention WITH Dr. Wolski

Incidence of Acute Urinary Retention (AUR)

  • Most common in men because most commonly 2/2 BPH

  • 1 in 10 men in their 70s will experience AUR

  • 1 in 3 men in their 80s will experience AUR

  • Catheters in escalating order

    • Foley first

    • Coude catheter

    • Silicone

    • Suprapubic- seldinger technique

  • Etiologies of acute urinary retention

    • Obstructive: BPH, neoplasm, bladder calculi, clots, (para)phimosis, urethral stricture, pelvic organ prolapse, gravid uterus, fecal impaction

    • Neurologic: Diabetic neuropathy, CVA, multiple sclerosis, cauda equina, Guillain-Barre, transverse myelitis, epidural abscess, spinal trauma

    • Infectious/inflammatory: cystitis/urethritis, prostatitis, vulvovaginitis, vaginal lichen planus or sclerosis, HSV or VZV, Lyme disease

    • Pharmacologic: antiarrhythmics, anticholinergics, antidepressants, antihistamines, antihypertensives, antiparkinsonians, antipsychotics, hormonal agents, muscle relaxants, sympathomimetics (alpha) and (beta)

    • Other: postpartum, epidural, trauma, general anesthesia, voiding dysfunction (pediatrics), pain, bladder overdistention, postoperative, psychogenic, bladder/urethral rupture

  • Physiologic Classification

    • Outflow obstruction: BPH, malignancy, stricture

    • Disruption of detrusor innervation: cauda equina, MS, Guillain-Barre, diabetes neuropathy

    • Bladder overdistention: general anesthesia/epidural, constipation, anticholinergics

  • Useful Diagnostics

    • History

      • Are they on any medications?

      • How long as the catheter been in place?

      • Any history of abdominal surgeries?

    • Physical Exam

      • Spinal tenderness?

      • Undress patients, evaluate for any GU infections

      • Rectal and/or pelvic exams

    • Lab tests

      • Urinalysis

      • CBC, BMP

    • Imaging

      • Bladder scan (urine volume >500ml)

      • Abdominal CT

      • Brain/spine MRI

  • Next steps

    • Observe for 2 hours: watch for post-obstructive diuresis, which can occur in up to 50% of acute urinary retention patients

      • >0.2L/hr for >3 hours: indicates post-obstructive diuresis which merits admission

    • Follow up in 3 days with urology, discharge on alpha blocker

  • Final tips

    • Empiric antibiotics after catheter placement? Not indicated

    • PSA? No


R2 CPC Myxedema Coma WITH Dr. Wright and Dr. Gawron

Patient: Elderly year-old male with unclear history presents to the ED after being found down. Fingerstick glucose noted to be 14. Given glucagon en route by EMS as unable to obtain IV access.

Diagnosis: Myxedema coma

Test of choice: TSH, Free T4

  • Epidemiology

    • Typically >60 years old

    • Often the first presentation of hypothyroidism

    • Underlying trigger: infection, medications, stroke, cold exposure

  • Pathophysiology

    • Vascular smooth muscle

    • Metabolism

    • Thermal regulation

    • Respiratory center

    • Coagulation

  • Typical presentation

    • Triad: hypothyroidism, mental status changes, hypoglycemia

    • Hypoventilation

    • Hyponatremia

    • Hypoglycemia

    • Hypotension

    • Elevated LFTs

    • Pericardial and/or pleural effusions

  • Management

    • Levothyroxine 4mcg/kg IV loading dose, then 75 to 100mcg daily until PO

    • T3 5-20 mcg IV, then 2.5 - 10mcg q8h

    • Hydrocortisone 100mg IV q8h

      • Give before levothyroxine 

    • If bleeding, try desmopressin

    • Respiratory support as needed

    • Hemodynamic support

      • Volume resuscitate

      • Pressors unlikely to be helpful

    • Avoid active rewarming- can cause vasodilation if a patient is volume down

    • Identification and treatment of underlying trigger

    • Admit to ICU

    • Mortality rate as high as 60%

    • Empirically treat for sepsis with broad spectrum antibiotics

  • Summary

    • Myxedema coma is a rare, life-threatening presentation of severe hypothyroidism

    • Presents with hypothermia, hypoglycemia, and altered mentation

    • Identify underlying trigger

    • Treat with 4mcg/kg IV levothyroxine, steroids, antibiotics, and ICU admission


R1 Clinical Diagnostics: Global Parasitic Infections WITH Dr. Schor

 Check out Dr. Schor’s infographics in the full post here

The Bot fly

  • Mode of transit

    • Primarily through mosquito bites

    • Female Bot fly lays eggs in vectors such as mosquitoes

    • The vector then bites humans and releases Botfly eggs  into the host. 

    • Self expulsion of the bot fly happens after about 5-10 weeks

    • Myiasis: infection of human tissue by fly larvae

  • Epidemiology

    • Endemic to Central and South America as well as Africa 

  • Treatment

    • Larvae need to be stunned or encouraged to leave as they have spines and hooks that impede simple removal

    • Stunning can be completed by injection of lidocaine with epi into and around the larvae. Injecting more fluid at the base of the lesion can then force the larvae out 

    • Engagement can be offered by causing asphyxiation of the larvae. This is accomplished through putting petroleum jelly over the area. After 3-24 hours the larvae will emerge seeking air. 

  • Ascaris

    • Intestinal roundworm that is most common in warm tropical environments and is more likely to thrive in areas with poor sanitation.  

    • Lifecycle 

      • Eggs are ingested from contaminated soil or water. The eggs then hatch in the small intestine and the larvae migrate to the lungs. In the lungs they mature over ~10 days, climb out of the bronchus and are swallowed back into the gi tract. They mature in the GI tract. As long as male and female worms are present in the GI tract the female will cause fertilized eggs to pass in the stool. 

    • Diagnosis 

      • Stool O&P

    • Treatment

      • Single dose of albendazole 400mg

  • Malaria

    • What is it

      • This focuses on falciparum though vivax, ovale, malariae and knowlesi are also important

      • Spread by anopheles mosquito

    • Where is it

      • Present  in a large swath of tropical and subtropical countries: Africa,  South & Central America, Southeast Asia, and the Caribbean

    • Presentation

      • Non-specific but including tachycardia, chills, malaise, headache, cough, abdominal pain, nausea, vomiting, diarrhea, and sometimes cyclic fevers. 

    • Diagnosis

      • Thick and thin blood smears + giemsa stain microscopy

    • Treatment

      • Amodiaquine/mefloquine/sulfadioxine-pyrimethamine for 3 days

      • Severe: IV Artesunate (through the CDC) for 24 hours plus a 3 day PO course

  • Babesiosis

    • What is it

      • Erythrocytic parasite that is spread by ixodes scapularis, the same deer tick that spreads Lyme disease

    • Where is it

      • Multiple species but primarily in the US it is seen in the northeast and upper midwest overlapping with Lyme disease

    • Presentation

      • Patients will have malaise, fevers, myalgias though it can also be subclinical. In asplenic patients it can result in anemia, jaundice and DIC. 

    • Diagnosis 

      • Blood smear showing maltese cross which is 4 parasites stuck in an erythrocyte. 

    • Treatment

      • Mild (<4% parasitemia): atovaquone (750mg BID) + azithromycin (500-1000mg day one then 250-1000mg) for a total of 10 days

      • Severe (>4% parasitemia): Clindamycin (600mg PO q8h) +quinine (650mg TID) for a total of 10 days

  • Cryptosporidium

    • What

      • Protozoa generally found in unclean drinking or swimming water which is found around the world

    • Presentation

      • Immunocompetent patients have self limited disease with watery diarrhea that resolves in 2 weeks

      • Immunocompromised patients can have copious diarrhea passing over a gallon of stool in a day resulting in severe dehydration. It can also cause cause acalculous cholecystitis, cough and shortness of breath

    • Diagnosis 

      • Stool acid fast stain showing oocysts and stool cultures showing protozoa

    • Treatment

      • Immunocompetent - likely no treatment needed but 500mg of nitazoxanide BID for 3d can be used if severe

      • Treatment is not approved for immunocompromised patients and starting ART is often best. 

  • Chagas

    • Aka Trypanasoma cruzi which is a protozoa spread by the reduviid bug.

    • Transmission

      • The Reduuvid bugs often bite sleeping humans near the lips and eyes while defecating. Humans then scratch the areas and become inoculated. 

    • Where is it

      • Endemic in the southern United States to the northern part of Argentina and Chile

    • How it Presents

      • Initially people will have signs of the initial bite from the Reduviid bug which will cause a chagoma(inflammation from the bite) and Romanas sign(orbital edema and conjunctivitis). 

      • Long term chagas leads to chronic inflammation causing dilated cardiomyopathy, megaesophagus, and megacolon. 

    • Diagnosis

      • Testing for antibodies for the parasite

    • Treatment

      • Benznidazole 5mg/kg/day for 60 days and nifurtimax 8-10mg/kg/day for 60-90 days)